Abstract: Systems and methods are provided for interconnecting proxy directories, through core proxy services. One example computer-implemented method includes receiving, by a first proxy service core computing device, from a participant, a proxy lookup request, where the proxy lookup request includes a proxy and based on one or more routing rules, submitting the proxy lookup request to a second proxy service core computing device. The method also includes receiving, by the first proxy service core computing device, from the second proxy service core computing device, a proxy lookup response, which includes account data linked to the proxy, and returning the proxy lookup response, to the participant, in response to the proxy lookup request.

Abstract: An exemplary compounding method of controlling a compounding device to prepare an admixture of at least two distinct material sources can include examining material source solutions for incompatibility of the ingredients and operating a first and a second pump to prevent one of the incompatible source solutions from entering a common flow path. The processing method can detect degradation of a fluid line by evaluating one or more of calibration error rate data, cumulative volumetric flow data, or cumulative pump operation data. The processing method can also selectively transfer a first group of source solutions using the first pump, receiving pump data from one or more sensors that sense actions of the pumps, applying fluid correction factors and calculating discrete pump movements, the pump movements being indicative of an amount of source solution displacement by a pump, and operating the pumps to selectively dispense the source solution amounts according to a preparation order.

Abstract: A knit hemostatic bandage provided herein can include a continuous rayon fiber and a continuous glass fiber. The knit hemostatic bandage can have a gauge of between 10 and 30 stitches per inch. The knit hemostatic bandage can have a Young's modulus of elasticity of less than 50 MPa.

Abstract: A knit hemostatic bandage provided herein can include a continuous rayon fiber and a continuous glass fiber. The knit hemostatic bandage can have a gauge of between 10 and 30 stitches per inch. The knit hemostatic bandage can have a Young's modulus of elasticity of less than 50 MPa.

Abstract: A knit hemostatic bandage provided herein can include a continuous rayon fiber and a continuous glass fiber. The knit hemostatic bandage can have a gauge of between 10 and 30 stitches per inch. The knit hemostatic bandage can have a Young's modulus of elasticity of less than 50 MPa.

Abstract: The invention relates to novel formulations comprising an organic semiconductor (OSC) and a conductive additive, to their use as conducting inks for the preparation of organic electronic (OE) devices, especially organic photovoltaic (OPV) cells, to methods for preparing OE devices using the novel formulations, and to OE devices and OPV cells prepared from such methods and formulations.

Abstract: A mobile device user is able to execute an app in a federation of wrapped apps without having to login to that app provided that the user has already logged into another app in that federation. The federation of apps on the device uses multi-app authentication to enable the user to start subsequent apps after explicitly entering login credentials for another app in that federation. This feature is loosely referred to as single sign-on for apps in the federation. The multi-app authentication is implemented by giving the second app a chance to prove two facts. One that it knows where in the operating system keychain a login ticket is stored and two, what the hash value of a random byte array is. By showing these facts, the logged-into app can safely provide login credentials to subsequent app without the user having to enter a login name or password.

Abstract: A keystore is installed on a mobile app where the keystore is created and provisioned on a server, such as an app wrapping server, under the control of an enterprise. A generic (non-provisioned) wrapped app is installed on a device. The app prompts the user to enter a passphrase. When the user does this, an app keystore is created. It has a user section and a table of contents. The keystore files are hashed, creating “first” keystore hash values. The first keystore hash values are stored in the TOC. The TOC is then hashed, creating a TOC hash value. The passphrase entered by the user is then combined with the TOC hash value. This creates a “first” master passphrase for the keystore. The keystore is then transmitted to the device where it is installed in the generic (non-provisioned) wrapped app.

Abstract: A mobile device user is able to execute an app in a federation of wrapped apps without having to login to that app provided that the user has already logged into another app in that federation. The federation of apps on the device uses multi-app authentication to enable the user to start subsequent apps after explicitly entering login credentials for another app in that federation. This feature is loosely referred to as single sign-on for apps in the federation. The multi-app authentication is implemented by giving the second app a chance to prove two facts. One that it knows where in the operating system keychain a login ticket is stored and two, what the hash value of a random byte array is. By showing these facts, the logged-into app can safely provide login credentials to subsequent app without the user having to enter a login name or password.

Abstract: A keystore is installed on a mobile app where the keystore is created and provisioned on a server, such as an app wrapping server, under the control of an enterprise. A generic (non-provisioned) wrapped app is installed on a device. The app prompts the user to enter a passphrase. When the user does this, an app keystore is created. It has a user section and a table of contents. The keystore files are hashed, creating “first” keystore hash values. The first keystore hash values are stored in the TOC. The TOC is then hashed, creating a TOC hash value. The passphrase entered by the user is then combined with the TOC hash value. This creates a “first” master passphrase for the keystore. The keystore is then transmitted to the device where it is installed in the generic (non-provisioned) wrapped app.

Abstract: A method for counting blood cells in a sample of whole blood. The method comprises the steps of: (a) providing a sample of whole blood; (b) depositing the sample of whole blood onto a slide, e.g., a microscope slide; (c) employing a spreader to create a blood smear; (d) allowing the blood smear to dry on the slide; (e) measuring absorption or reflectance of light attributable to the hemoglobin in the red blood cells in the blood smear on the slide; (f) recording a magnified two-dimensional digital image of the area of analysis identified by the measurement in step (e) as being of suitable thickness for analysis; and (g) collecting, analyzing, and storing data from the magnified two-dimensional digital image. Optionally, steps of fixing and staining of blood cells on the slide can be employed in the method.

Abstract: A knit hemostatic bandage provided herein can include a continuous rayon fiber and a continuous glass fiber. The knit hemostatic bandage can have a gauge of between 10 and 30 stitches per inch. The knit hemostatic bandage can have a Young's modulus of elasticity of less than 50 MPa.

Abstract: The present invention is directed to novel pharmaceutical compositions comprising fixed dose combinations of a dipeptidyl peptidase-4 inhibitor (DPP-4 inhibitor), or a pharmaceutically acceptable salt thereof, and simvastatin, or pharmaceutically acceptable salt thereof, methods of preparing such pharmaceutical compositions, and methods of treating Type 2 diabetes and hypercholesterolemia with such pharmaceutical compositions. In particular, the invention is directed to pharmaceutical compositions comprising fixed-dose combinations of sitagliptin phosphate and simvastatin.

Abstract: A security-wrapped app that is locked and inaccessible is unlocked and recovered using a secure and user-friendly protocol. Apps that are security wrapped are passphrase protected. The app security keystore on the device becomes locked. The keystore is encrypted with a recovery key which is only in an encrypted form on the device and cannot be decrypted or otherwise accessed by the user. As such, the user cannot unlock the keystore on the device and therefore is not able to unlock the app. The app can be unlocked using a recovery mechanism that is highly secure in all communications between the mobile device and the service provider server. At the same time the recovery mechanism is easy for the end user to carry out.

Abstract: The present invention relates to methods of using the compound, N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl) -1-phthalazinamine, to treat cancers, including solid tumors, which have become resistant to treatment with chemotherapeutic agents, including anti-mitotic agents such as taxanes, and/or other anti-cancer agents, including aurora kinase inhibiting agents. The invention also includes methods of treating cancers refractory to such treatments by administering a pharmaceutical composition, comprising the compound to a cancer subject.

Abstract: A method for counting blood cells in a sample of whole blood. The method comprises the steps of: (a) providing a sample of whole blood; (b) depositing the sample of whole blood onto a slide, e.g., a microscope slide; (c) employing a spreader to create a blood smear; (d) allowing the blood smear to dry on the slide; (e) measuring absorption or reflectance of light attributable to the hemoglobin in the red blood cells in the blood smear on the slide; (f) recording a magnified two-dimensional digital image of the area of analysis identified by the measurement in step (e) as being of suitable thickness for analysis; and (g) collecting, analyzing, and storing data from the magnified two-dimensional digital image. Optionally, steps of fixing and staining of blood cells on the slide can be employed in the method.

Abstract: The invention relates to novel formulations comprising an organic semiconductor (OSC) and a conductive additive, to their use as conducting inks for the preparation of organic electronic (OE) devices, especially organic photovoltaic (OPV) cells, to methods for preparing OE devices using the novel formulations, and to OE devices and OPV cells prepared from such methods and formulations.

Abstract: The invention provides methods for using Ang2 inhibitors in combination with VEGF inhibitors to treat disease. The invention also provides compositions, kits, formulations, and specific disease treatments relating thereto.

Abstract: A chemical vapor sterilization process is enhanced by concentrating a germicide via condensation and re-vaporization thereof, exploiting the difference between the vapor pressures of the germicide and its solvent to extract some of the solvent during the condensation process. A heat pump coupled with the condensation surface enhances the speed and efficiency of condensing and revaporizing the germicide.

Abstract: The vascular endothelial cell growth factor (VEGF) inhibitors of the present invention are naturally occurring or recombinantly engineered soluble forms with or without a C-terminal transmembrane region of the receptor for VEGF, a very selective growth factor for endothelial cells. The soluble forms of the receptors will bind the growth factor with high affinity but do not result in signal transduction. These soluble forms of the receptor bind VEGF and inhibit its function.